NCT00150410

Brief Summary

  • Whether a combination of three therapies - metformin and a sulfonylurea plus Exubera, an investigational drug, controls your diabetes at least as much as a triple combination therapy of metformin and a sulfonylurea plus Avandia, a Food and Drug Administration (FDA) approved drug.
  • Whether a combination of two therapies - metformin plus Exubera controls your diabetes at least as much as a as a triple combination therapy of metformin and a sulfonylurea plus Avandia.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
626

participants targeted

Target at P75+ for phase_3 diabetes-mellitus

Timeline
Completed

Started Jan 2003

Longer than P75 for phase_3 diabetes-mellitus

Geographic Reach
5 countries

119 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2003

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

September 6, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 8, 2005

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2007

Completed
Last Updated

October 31, 2008

Status Verified

October 1, 2008

First QC Date

September 6, 2005

Last Update Submit

October 28, 2008

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glycosylated hemoglobin

Secondary Outcomes (4)

  • Change from baseline in fasting plasma glucose. Other secondary efficacy

  • endpoints include, body weight, patient reported outcomes, incidence and severity

  • of hypoglycemic episodes, cough questionnaire, and discontinuation rate due to

  • insufficient clinical response.

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 diabetes
  • Currently treated and on a stable doses of drugs for the preceding two (2) months

You may not qualify if:

  • Type 1 Diabetes
  • Smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (119)

Pfizer Investigational Site

Mesa, Arizona, 85205, United States

Location

Pfizer Investigational Site

Phoenix, Arizona, 85012, United States

Location

Pfizer Investigational Site

Tucson, Arizona, 85715, United States

Location

Pfizer Investigational Site

Searcy, Arkansas, 72143, United States

Location

Pfizer Investigational Site

Alhambra, California, 91801, United States

Location

Pfizer Investigational Site

Concord, California, 94520, United States

Location

Pfizer Investigational Site

Huntington Beach, California, 92647, United States

Location

Pfizer Investigational Site

Huntington Beach, California, 92648, United States

Location

Pfizer Investigational Site

La Jolla, California, 92037, United States

Location

Pfizer Investigational Site

Long Beach, California, 90805, United States

Location

Pfizer Investigational Site

Long Beach, California, 90806, United States

Location

Pfizer Investigational Site

Los Angeles, California, 90048, United States

Location

Pfizer Investigational Site

Riverside, California, 92506, United States

Location

Pfizer Investigational Site

Santa Barbara, California, 93105, United States

Location

Pfizer Investigational Site

Tustin, California, 92780, United States

Location

Pfizer Investigational Site

Westminster, California, 92683, United States

Location

Pfizer Investigational Site

Denver, Colorado, 80209, United States

Location

Pfizer Investigational Site

Wheat Ridge, Colorado, 80033, United States

Location

Pfizer Investigational Site

Waterbury, Connecticut, 06708, United States

Location

Pfizer Investigational Site

Washington D.C., District of Columbia, 20010, United States

Location

Pfizer Investigational Site

Washington D.C., District of Columbia, 20307, United States

Location

Pfizer Investigational Site

Hollywood, Florida, 33021, United States

Location

Pfizer Investigational Site

West Palm Beach, Florida, 33401, United States

Location

Pfizer Investigational Site

Winter Park, Florida, 32789, United States

Location

Pfizer Investigational Site

Atlanta, Georgia, 30309, United States

Location

Pfizer Investigational Site

Augusta, Georgia, 30909, United States

Location

Pfizer Investigational Site

Savannah, Georgia, 31405, United States

Location

Pfizer Investigational Site

Savannah, Georgia, 31419, United States

Location

Pfizer Investigational Site

Honolulu, Hawaii, 96813, United States

Location

Pfizer Investigational Site

‘Ewa Beach, Hawaii, 96706, United States

Location

Pfizer Investigational Site

Idaho Falls, Idaho, 83404-6370, United States

Location

Pfizer Investigational Site

Idaho Falls, Idaho, 83404-7542, United States

Location

Pfizer Investigational Site

Chicago Heights, Illinois, 60411, United States

Location

Pfizer Investigational Site

Indianapolis, Indiana, 46202, United States

Location

Pfizer Investigational Site

Des Moines, Iowa, 50314, United States

Location

Pfizer Investigational Site

Wichita, Kansas, 67203, United States

Location

Pfizer Investigational Site

Lexington, Kentucky, 40503, United States

Location

Pfizer Investigational Site

Louisville, Kentucky, 40213, United States

Location

Pfizer Investigational Site

Baton Rouge, Louisiana, 70808, United States

Location

Pfizer Investigational Site

New Orleans, Louisiana, 70112, United States

Location

Pfizer Investigational Site

Baltimore, Maryland, 21204, United States

Location

Pfizer Investigational Site

Springfield, Massachusetts, 01103, United States

Location

Pfizer Investigational Site

Springfield, Massachusetts, 01199, United States

Location

Pfizer Investigational Site

Waltham, Massachusetts, 02453, United States

Location

Pfizer Investigational Site

West Saint Paul, Minnesota, 55118, United States

Location

Pfizer Investigational Site

North Kansas City, Missouri, 64116, United States

Location

Pfizer Investigational Site

St Louis, Missouri, 63141, United States

Location

Pfizer Investigational Site

Butte, Montana, 59701, United States

Location

Pfizer Investigational Site

Lincoln, Nebraska, 68521, United States

Location

Pfizer Investigational Site

New Brunswick, New Jersey, 08901, United States

Location

Pfizer Investigational Site

New Brunswick, New Jersey, 08903, United States

Location

Pfizer Investigational Site

Albuquerque, New Mexico, 87106, United States

Location

Pfizer Investigational Site

Albany, New York, 12208, United States

Location

Pfizer Investigational Site

Flushing, New York, 11365, United States

Location

Pfizer Investigational Site

Mineola, New York, 11501, United States

Location

Pfizer Investigational Site

New Hyde Park, New York, 11042, United States

Location

Pfizer Investigational Site

Rochester, New York, 14642, United States

Location

Pfizer Investigational Site

Raleigh, North Carolina, 27609, United States

Location

Pfizer Investigational Site

Cincinnati, Ohio, 45229, United States

Location

Pfizer Investigational Site

Cleveland, Ohio, 44195, United States

Location

Pfizer Investigational Site

Lakewood, Ohio, 44107, United States

Location

Pfizer Investigational Site

Oklahoma City, Oklahoma, 73104, United States

Location

Pfizer Investigational Site

Portland, Oregon, 97210, United States

Location

Pfizer Investigational Site

Pittsburgh, Pennsylvania, 15235, United States

Location

Pfizer Investigational Site

Charleston, South Carolina, 29401-5799, United States

Location

Pfizer Investigational Site

Charleston, South Carolina, 29425, United States

Location

Pfizer Investigational Site

Duncan, South Carolina, 29334, United States

Location

Pfizer Investigational Site

Spartanburg, South Carolina, 29303, United States

Location

Pfizer Investigational Site

Spartanburg, South Carolina, 29307, United States

Location

Pfizer Investigational Site

Sumter, South Carolina, 29150, United States

Location

Pfizer Investigational Site

Kingsport, Tennessee, 37660, United States

Location

Pfizer Investigational Site

Knoxville, Tennessee, 37909, United States

Location

Pfizer Investigational Site

Memphis, Tennessee, 38119, United States

Location

Pfizer Investigational Site

Nashville, Tennessee, 37232, United States

Location

Pfizer Investigational Site

Corpus Christi, Texas, 78411, United States

Location

Pfizer Investigational Site

Dallas, Texas, 75230, United States

Location

Pfizer Investigational Site

Dallas, Texas, 75246, United States

Location

Pfizer Investigational Site

El Paso, Texas, 79925, United States

Location

Pfizer Investigational Site

El Paso, Texas, 79935, United States

Location

Pfizer Investigational Site

San Antonio, Texas, 78229, United States

Location

Pfizer Investigational Site

San Antonio, Texas, 78237, United States

Location

Pfizer Investigational Site

Ogden, Utah, 84403, United States

Location

Pfizer Investigational Site

Fredericksburg, Virginia, 22401, United States

Location

Pfizer Investigational Site

Richmond, Virginia, 23221, United States

Location

Pfizer Investigational Site

Richmond, Virginia, 23294, United States

Location

Pfizer Investigational Site

Renton, Washington, 98055, United States

Location

Pfizer Investigational Site

Tukwila, Washington, 98188, United States

Location

Pfizer Investigational Site

Milwaukee, Wisconsin, 53209, United States

Location

Pfizer Investigational Site

Camperdown, New South Wales, 2050, Australia

Location

Pfizer Investigational Site

Wollongong, New South Wales, 2500, Australia

Location

Pfizer Investigational Site

Herston, Queensland, 4029, Australia

Location

Pfizer Investigational Site

Woolloongabba, Queensland, 4102, Australia

Location

Pfizer Investigational Site

Keswick, South Australia, 5035, Australia

Location

Pfizer Investigational Site

Box Hill, Victoria, 3128, Australia

Location

Pfizer Investigational Site

Caulfield, Victoria, 3162, Australia

Location

Pfizer Investigational Site

Porto Alegre, Rio Grande do Sul, 90035-170, Brazil

Location

Pfizer Investigational Site

São Paulo, São Paulo, 01244-030, Brazil

Location

Pfizer Investigational Site

São Paulo, São Paulo, 04231-030, Brazil

Location

Pfizer Investigational Site

Winnipeg, Manitoba, R3E 3P4, Canada

Location

Pfizer Investigational Site

London, Ontario, N6A 4V2, Canada

Location

Pfizer Investigational Site

Mississauga, Ontario, L5M2V8, Canada

Location

Pfizer Investigational Site

Oakville, Ontario, L6H 3P1, Canada

Location

Pfizer Investigational Site

Thornhill, Ontario, L4J 1V8, Canada

Location

Pfizer Investigational Site

Toronto, Ontario, M4N-3M5, Canada

Location

Pfizer Investigational Site

Toronto, Ontario, M4R 2G4, Canada

Location

Pfizer Investigational Site

Laval, Quebec, H7T 2P5, Canada

Location

Pfizer Investigational Site

Montreal, Quebec, H1T 2M4, Canada

Location

Pfizer Investigational Site

Saint-Jérôme, Quebec, J7Z 5T3, Canada

Location

Pfizer Investigational Site

Vaudreuil, Quebec, J7V 8P9, Canada

Location

Pfizer Investigational Site

St. John's, A1E 2E2, Canada

Location

Pfizer Investigational Site

Guadalajara, Jalisco, 44340, Mexico

Location

Pfizer Investigational Site

Guadalajara, Jalisco, 44349, Mexico

Location

Pfizer Investigational Site

Guadalajara, Jalisco, 44660, Mexico

Location

Pfizer Investigational Site

Guadalajara, Jalisco/Mexico, 44347, Mexico

Location

Pfizer Investigational Site

Mexico City, Mexico City, 02990, Mexico

Location

Pfizer Investigational Site

Mexico City, Mexico City, 03100, Mexico

Location

Pfizer Investigational Site

Monterrey, Nuevo León, 64060, Mexico

Location

Pfizer Investigational Site

Jalapa, Veracruz, 91020, Mexico

Location

Pfizer Investigational Site

Mexico City, CP 14000, Mexico

Location

Related Links

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 6, 2005

First Posted

September 8, 2005

Study Start

January 1, 2003

Study Completion

June 1, 2007

Last Updated

October 31, 2008

Record last verified: 2008-10

Locations